|
BSDC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.63910004960621E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.19715390115516E-12 |
| Normal-vs-Stage2 |
8.188100E-04 |
| Normal-vs-Stage3 |
1.386560E-04 |
| Normal-vs-Stage4 |
1.457040E-03 |
| Stage1-vs-Stage2 |
5.525800E-01 |
| Stage1-vs-Stage3 |
4.492400E-01 |
| Stage1-vs-Stage4 |
3.543000E-01 |
| Stage2-vs-Stage3 |
9.588800E-01 |
| Stage2-vs-Stage4 |
3.010200E-01 |
| Stage3-vs-Stage4 |
2.595600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.75570002980407E-10 |
| Normal-vs-AfricanAmerican |
2.97129987281153E-10 |
| Normal-vs-Asian |
4.996200E-02 |
| Caucasian-vs-AfricanAmerican |
1.848980E-01 |
| Caucasian-vs-Asian |
4.666600E-01 |
| AfricanAmerican-vs-Asian |
6.366000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.21651643892574E-12 |
| Normal-vs-Female |
1.76380000049825E-07 |
| Male-vs-Female |
1.722980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.97969995741465E-09 |
| Normal-vs-Extreme_Weight |
5.27889953971794E-11 |
| Normal-vs-Obese |
4.39650005290559E-09 |
| Normal-vs-Extreme_Obese |
3.991500E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.975200E-01 |
| Normal_Weight-vs-Obese |
5.152400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.172800E-01 |
| Extreme_Weight-vs-Obese |
6.406600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.926600E-01 |
| Obese-vs-Extreme_Obese |
5.364200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.418780E-04 |
| Normal-vs-Age(41-60Yrs) |
8.60949977976588E-10 |
| Normal-vs-Age(61-80Yrs) |
5.44260192469892E-11 |
| Normal-vs-Age(81-100Yrs) |
3.06470000044357E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.654800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.786800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.677800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.324000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.617200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.043800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.77510261834391E-11 |
| Normal-VS-Type2 PRCC |
7.03570002258402E-09 |
| Normal-VS-KIRP CIMP |
2.238200E-02 |
| Normal-VS-Unclassified PRCC |
3.581200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.920000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.911200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.122400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.179400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.936450E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.605000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.90060000649606E-09 |
| Normal-vs-N1 |
1.900150E-02 |
| Normal-vs-N2 |
3.513800E-01 |
| N0-vs-N1 |
7.465600E-01 |
| N0-vs-N2 |
4.413000E-01 |
| N1-vs-N2 |
8.107600E-01 |
|
|
